While it has been approved in India for blood sugar control, its other benefits include weight reduction and lowered risk of ...

Ocular Therapeutix has seen its fair value estimate rise from $17.45 to $20.17 per share, signaling increased analyst confidence in the company’s key programs. While the discount rate remains steady ...

The demand for advanced diagnostic technologies in optometry and ophthalmology is accelerating as clinics increasingly adopt ...

It's not only caused by needing corrective lenses. Leading eye doctors share which conditions—big and small—can cause blurry vision.